Opus Genetics, Inc. (IRD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.25B |
| Enterprise Value | 1.21B |
| P/E Ratio | -31.69 |
| PEG Ratio | 0.84 |
| Price/Sales Ratio | 26.87 |
| Price/Book Ratio | -73.93 |
| Enterprise/Revenue | 24.03 |
| Enterprise/EBITDA | -2.75 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -8.92 |
| Operating Margin | -3.59 |
| Return On Assets | -1.6 |
| Return On Equity | 60.69 |
| Revenue | 14.2M |
| Revenue/Share | 0.01 |
| Gross Profit | 14.2M |
| EBITDA | -48.07M |
| Net Income | -49.59M |
| Diluted EPS | -0.8 |
| Total Cash | 59.96M |
| Total Cash/Share | 0.07 |
| Total Debt | 25.93M |
| Total Debt/Equity | -0.57 |
| Current Ratio | 7.13 |
| Book Value Per Share | -0.05 |
| 52-Week Change | 322.26 |
| 52-Week High | 5.81 |
| 52-Week Low | 0.9 |
| Moving Average 50 Days | 4.79 |
| Moving Average 200 Days | 3.13 |
| Average Volume | 806,358 |
| Shares Outstanding | 82.57M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | November 06, 2020 |